Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 27, 2017

DrugPatentWatch Database Preview

Paroxetine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for paroxetine hydrochloride and what is the scope of paroxetine hydrochloride freedom to operate?

Paroxetine hydrochloride
is the generic ingredient in four branded drugs marketed by Mylan, Aurobindo Pharma, Apotex Technologies, Mylan Pharms Inc, Teva, Roxane, Jubilant Generics, Lupin Ltd, Kremers Urban Pharms, Prinston Inc, Apotex, Upsher-smith Labs, Oxford Pharms, Teva Pharms, Zydus Pharms Usa, Sun Pharm Inds Inc, and Apotex Inc, and is included in twenty-two NDAs. There are six patents protecting this compound and three Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Paroxetine hydrochloride has two hundred and thirteen patent family members in fifty-one countries.

There are thirty drug master file entries for paroxetine hydrochloride. Fifty-four suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: paroxetine hydrochloride

Tradenames:4
Patents:6
Applicants:17
NDAs:22
Drug Master File Entries: see list30
Suppliers / Packagers: see list54
Bulk Api Vendors: see list107
Clinical Trials: see list1,043
Patent Applications: see list5,735
Therapeutic Class:Anxiolytics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:paroxetine hydrochloride at DailyMed

Pharmacology for Ingredient: paroxetine hydrochloride

Tentative approvals for PAROXETINE HYDROCHLORIDE

Applicant Application No. Strength Dosage Form
► Subscribe► SubscribeEQ 10MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 40MG BASETABLET;ORAL
► Subscribe► SubscribeEQ 30MG BASETABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Jubilant Generics
PAROXETINE HYDROCHLORIDE
paroxetine hydrochloride
TABLET;ORAL205528-001Nov 27, 2015ABRXNoNo► Subscribe► Subscribe
Zydus Pharms Usa
PAROXETINE HYDROCHLORIDE
paroxetine hydrochloride
TABLET;ORAL077584-001Mar 7, 2007ABRXNoNo► Subscribe► Subscribe
Lupin Ltd
PAROXETINE HYDROCHLORIDE
paroxetine hydrochloride
TABLET, EXTENDED RELEASE;ORAL204134-002Jan 20, 2017ABRXNoNo► Subscribe► Subscribe
Jubilant Generics
PAROXETINE HYDROCHLORIDE
paroxetine hydrochloride
TABLET;ORAL205528-002Nov 27, 2015ABRXNoNo► Subscribe► Subscribe
Oxford Pharms
PAROXETINE HYDROCHLORIDE
paroxetine hydrochloride
TABLET;ORAL076968-001Jun 21, 2010ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot